Promoting safer clozapine dosing in the Americas

Affiliations

¹ Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA. Centro de Investigación Biomédica en Red de Salud Mental, Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain.
² Departamento de Fisiología, Facultad de Medicina, Universidad de los Andes, Mérida, Venezuela.
³ Instituto Vilapriño, Centro de Estudios, Asistencia e Investigación en Neurociencias, Mendoza, Argentina.
⁴ Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China. The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
⁵ Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland. The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA.
⁶ Departamento de Medicina Interna, Dermatología y Psiquiatría, Instituto Universitario de Neurociencia, Universidad de La Laguna, Canary Islands, Spain.

Editorial

Jose de Leon et al. Braz J Psychiatry. 2022.

. 2022 Sep 22;44(4):363-365.

doi: 10.47626/1516-4446-2021-0041.

¹ Mental Health Research Center, Eastern State Hospital, Lexington, KY, USA. Centro de Investigación Biomédica en Red de Salud Mental, Santiago Apóstol Hospital, University of the Basque Country, Vitoria, Spain.
² Departamento de Fisiología, Facultad de Medicina, Universidad de los Andes, Mérida, Venezuela.
³ Instituto Vilapriño, Centro de Estudios, Asistencia e Investigación en Neurociencias, Mendoza, Argentina.
⁴ Laboratory of Clinical Psychopharmacology, Beijing Anding Hospital, Capital Medical University, Beijing, China. The National Clinical Research Centre for Mental Disorders & Beijing Key Lab of Mental Disorders, Beijing Anding Hospital, Capital Medical University, Beijing, China.
⁵ Department of Psychiatry, Psychotherapy and Psychosomatics, Psychiatric Hospital, University of Zürich, Zürich, Switzerland. The Zucker Hillside Hospital, Psychiatry Research, Northwell Health, Glen Oaks, New York, USA.
⁶ Departamento de Medicina Interna, Dermatología y Psiquiatría, Instituto Universitario de Neurociencia, Universidad de La Laguna, Canary Islands, Spain.

No abstract available

Conflict of interest statement

GS has served as a consultant for HLS Therapeutics. The other authors report no conflicts of interest.

1. de Leon J, Schoretsanitis G, Smith RL, Molden E, Solismaa A, Seppälä N, et al. An international adult guideline for making clozapine titration safer by using six ancestry-based personalized dosing titrations, CRP, and clozapine levels. Pharmacopsychiatry. 2021 Dec 15 doi: 10.1055/a-1625-6388. . Online ahead of print. - DOI - PubMed
1. Nielsen R, Akey JM, Jakobsson M, Pritchard JK, Tishkoff S, Willerslev E. Tracing the peopling of the world through genomics. Nature. 2017;541:302–10. - PMC - PubMed
1. de Leon J, Ruan CJ, Schoretsanitis G, De Las Cuevas C. A rational use of clozapine based on adverse drug reactions, pharmacokinetics, and clinical pharmacopsychology. Psychother Psychosom. 2020;89:200–14. - PMC - PubMed
1. Ruan CJ, de Leon J. Is there a future for CYP1A2 pharmacogenetics in the optimal dosing of clozapine? Pharmacogenomics. 2020;21:369–73. - PubMed
1. Ruan CJ, Zang YN, Cheng YH, Wang CY, de Leon J. Around 3% of 1,300 levels were elevated during infections in a retrospective review of 131 Beijing Hospital in-patients with more than 24,000 days of clozapine treatment. Psychother Psychosom. 2020;89:255–7. - PubMed